Talis Biomedical Corp Price History

If you're considering investing in Talis Pink Sheet, it is important to understand the factors that can impact its price. Talis Biomedical Corp owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.76, which indicates the firm had a -0.76% return per unit of risk over the last 3 months. Talis Biomedical Corp exposes fifteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Talis Biomedical's Risk Adjusted Performance of (0.13), coefficient of variation of (556.77), and Variance of 110.16 to confirm the risk estimate we provide.
  
Talis Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.7633

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsTLIS

Estimated Market Risk

 51.36
  actual daily
96
96% of assets are less volatile

Expected Return

 -39.2
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.76
  actual daily
0
Most of other assets perform better
Based on monthly moving average Talis Biomedical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Talis Biomedical by adding Talis Biomedical to a well-diversified portfolio.

Talis Biomedical Pink Sheet Price History Chart

There are several ways to analyze Talis Stock price data. The simplest method is using a basic Talis candlestick price chart, which shows Talis Biomedical price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.

Talis Pink Sheet Price History Data

The price series of Talis Biomedical for the period between Sat, Aug 31, 2024 and Fri, Nov 29, 2024 has a statistical range of 7.92 with a coefficient of variation of 34.06. The price distribution for the period has arithmetic mean of 7.08. The median price for the last 90 days is 8.54. The company completed stock split (1:15) on 6th of July 2023.
OpenHighLowCloseVolume
09/06/2024 0.00  0.00  0.00  0.00  1.00 
09/05/2024 1.37  1.72  1.37  1.46  136,885 
09/04/2024 2.65  2.65  1.37  1.37  172,654 
09/03/2024 4.00  4.01  3.66  3.74  36,185 
08/30/2024 4.21  4.48  4.00  4.38  51,017 
08/29/2024 4.18  4.49  4.10  4.16  27,608 
08/28/2024 3.87  4.10  3.87  4.10  4,167 
08/27/2024 3.93  3.97  3.76  3.89  17,604 
08/26/2024 3.71  4.19  3.42  4.04  65,708 
08/23/2024 4.27  4.64  4.27  4.52  23,581 
08/22/2024 4.16  4.89  4.16  4.29  22,801 
08/21/2024 4.28  4.43  4.24  4.43  15,288 
08/20/2024 4.04  4.50  4.04  4.25  73,704 
08/19/2024 4.46  4.47  4.38  4.41  11,456 
08/16/2024 4.07  4.38  3.94  4.36  34,794 
08/15/2024 4.03  4.20  4.03  4.14  10,165 
08/14/2024 3.99  4.22  3.90  4.01  61,988 
08/13/2024 4.17  4.17  4.07  4.10  20,513 
08/12/2024 3.78  4.12  3.78  3.96  42,397 
08/09/2024 3.97  4.24  3.75  3.76  17,845 
08/08/2024 4.40  4.55  3.93  4.21  80,628 
08/07/2024 4.52  5.00  4.16  4.55  315,446 
08/06/2024 9.15  9.35  8.71  8.98  69,771 
08/05/2024 8.71  9.00  8.60  8.87  11,134 
08/02/2024 9.00  9.00  8.41  8.90  2,443 
08/01/2024 8.88  9.00  8.76  8.80  11,212 
07/31/2024 8.68  8.68  8.68  8.68  441.00 
07/30/2024 8.46  8.59  8.40  8.47  12,471 
07/29/2024 8.53  8.63  8.40  8.48  1,505 
07/26/2024 8.70  8.70  8.33  8.33  5,588 
07/25/2024 8.52  8.66  8.52  8.66  2,145 
07/24/2024 8.39  8.62  8.30  8.62  2,892 
07/23/2024 8.65  8.74  8.54  8.64  3,310 
07/22/2024 8.66  8.66  8.66  8.66  508.00 
07/19/2024 8.74  8.74  8.74  8.74  1,393 
07/18/2024 8.74  8.74  8.74  8.74  1,522 
07/17/2024 8.60  8.83  8.54  8.54  1,396 
07/16/2024 8.51  8.83  8.50  8.68  16,751 
07/15/2024 8.44  8.44  8.44  8.44  326.00 
07/12/2024 8.41  8.74  8.39  8.50  9,851 
07/11/2024 8.53  8.53  8.32  8.32  6,462 
07/10/2024 8.50  8.66  8.45  8.51  9,682 
07/09/2024 8.70  8.70  8.70  8.70  1,301 
07/08/2024 8.55  8.86  8.55  8.62  7,630 
07/05/2024 8.61  8.88  8.60  8.68  4,476 
07/03/2024 8.67  8.86  8.44  8.60  8,566 
07/02/2024 8.99  8.99  8.35  8.50  10,107 
07/01/2024 8.35  8.88  8.31  8.43  8,244 
06/28/2024 8.40  8.90  8.31  8.66  9,272 
06/27/2024 8.25  8.89  8.25  8.62  7,447 
06/26/2024 8.51  8.51  8.26  8.50  7,285 
06/25/2024 8.50  8.94  8.50  8.80  1,667 
06/24/2024 8.80  8.80  8.53  8.54  1,180 
06/21/2024 8.51  8.86  8.32  8.86  14,322 
06/20/2024 8.25  8.90  8.25  8.70  16,138 
06/18/2024 8.50  8.50  8.29  8.29  2,518 
06/17/2024 8.87  9.02  8.55  8.60  16,175 
06/14/2024 8.91  8.91  8.91  8.91  796.00 
06/13/2024 9.11  9.11  8.99  8.99  507.00 
06/12/2024 9.06  9.15  8.89  9.15  4,245 
06/11/2024 9.25  9.25  8.88  9.00  13,136 

About Talis Biomedical Pink Sheet history

Talis Biomedical investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Talis is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Talis Biomedical Corp will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Talis Biomedical stock prices may prove useful in developing a viable investing in Talis Biomedical
Talis Biomedical Corporation operates as a molecular diagnostic company. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Menlo Park, California. Talis Biomedical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 242 people.

Talis Biomedical Pink Sheet Technical Analysis

Talis Biomedical technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
A focus of Talis Biomedical technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Talis Biomedical trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run USA ETFs Now

   

USA ETFs

Find actively traded Exchange Traded Funds (ETF) in USA
All  Next Launch Module

Talis Biomedical Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Talis Biomedical's price direction in advance. Along with the technical and fundamental analysis of Talis Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Talis to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Consideration for investing in Talis Pink Sheet

If you are still planning to invest in Talis Biomedical Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Talis Biomedical's history and understand the potential risks before investing.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities